Page last updated: 2024-12-06

acetylurea

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Acetylurea is a compound with the formula CH3CONHCONH2. It is a white solid that is soluble in water. Acetylurea is a synthetic compound that is not found naturally. It can be prepared by reacting urea with acetic anhydride. Acetylurea has been studied for its potential use as a pesticide and herbicide, but it has not been widely used for these purposes. It has also been studied for its potential use as a medicine, but it is not currently used for this purpose. Acetylurea is a relatively simple molecule, and its synthesis is straightforward. Research on acetylurea has focused on its potential biological activity. While research on acetylurea continues, it remains a relatively obscure compound. Its potential applications are still under investigation.'

Cross-References

ID Source	ID
PubMed CID	68956
SCHEMBL ID	1696471
MeSH ID	M0065085

Synonyms (39)

Synonym
AKOS009031572
EN300-19984
1-acetylurea
acetic acid, ureide
acetylurea
monoacetylurea
acetylcarbamide
n-acetylurea
591-07-1
nsc2766
urea, acetyl-
nsc-2766
acetamide, n-(aminocarbonyl)-
nsc 2766
ai3-03704
n-(aminocarbonyl)acetamide
brn 1751301
einecs 209-698-3
n-carbamoylacetamide
A0124
n-carbamoyl-acetamide
3-03-00-00119 (beilstein handbook reference)
8kru31i919 ,
unii-8kru31i919
BP-10047
FT-0621837
DTXSID9060445
acetylharnstoff
SCHEMBL1696471
GKRZNOGGALENQJ-UHFFFAOYSA-N
mfcd00038140
STL194283
n-(aminocarbonyl)acetamide (synonym: acetylurea)
Q27270682
D88216
acetyl-urea
A856570
1-acetn-carbamoylacetamideylurea
Z104476284

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	11 (91.67)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (8.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	42.34 (24.57)
Research Supply Index	2.56 (2.92)
Research Growth Index	4.14 (4.65)
Search Engine Demand Index	61.55 (26.88)
Search Engine Supply Index	2.00 (0.95)

This Compound (42.34)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	12 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
urea pseudourea: clinical use; structure. isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.	3.8	12	isourea; monocarboxylic acid amide; one-carbon compound	Daphnia magna metabolite; Escherichia coli metabolite; fertilizer; flour treatment agent; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
phenacemide phenacemide: anti-epileptic drug; structure	3.43	8	acetamides
hydantoins Hydantoins: Compounds based on imidazolidine dione. Some derivatives are ANTICONVULSANTS.. imidazolidine-2,4-dione : An imidazolidinone with oxo groups at position 2 and 4.	1.92	1	imidazolidine-2,4-dione

Condition	Relationship Strength	Studies
Aura [description not available]	3.18	6
Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)	3.18	6
Absence Seizure [description not available]	2.62	3
Seizures Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.	7.62	3
Anemia, Hypoplastic [description not available]	1.92	1
Anemia A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.	1.92	1
Anemia, Aplastic A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.	1.92	1
Hepatorenal Syndrome Functional KIDNEY FAILURE in patients with liver disease, usually LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL), and in the absence of intrinsic renal disease or kidney abnormality. It is characterized by intense renal vasculature constriction, reduced renal blood flow, OLIGURIA, and sodium retention.	1.92	1

chemdatabank.com